These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 8289310

  • 1. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA, Stewart J, Benkovic SJ, Getzoff ED.
    J Mol Biol; 1994 Jan 21; 235(3):1098-116. PubMed ID: 8289310
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM, Olender EH, Arvai AS, Koike CK, Canestrelli IL, Stewart JD, Benkovic SJ, Getzoff ED, Roberts VA.
    J Mol Biol; 1999 Aug 13; 291(2):329-45. PubMed ID: 10438624
    [Abstract] [Full Text] [Related]

  • 3. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H, Hara T, Tanimura R, Fukuyama S, Cagnon C, Kohara A, Fujii I.
    J Mol Biol; 1997 Apr 18; 267(5):1247-57. PubMed ID: 9150409
    [Abstract] [Full Text] [Related]

  • 4. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW, Shan L, Broomell C, Ramsland PA, Fan Z, Anchin JM, Linthicum DS, Edmundson AB.
    J Mol Biol; 2000 Sep 29; 302(4):853-72. PubMed ID: 10993728
    [Abstract] [Full Text] [Related]

  • 5. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD, Schultz PG.
    J Mol Biol; 1998 Jan 09; 275(1):95-111. PubMed ID: 9451442
    [Abstract] [Full Text] [Related]

  • 6. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B, Stetefeld J.
    Biochemistry; 2004 Jun 01; 43(21):6612-9. PubMed ID: 15157094
    [Abstract] [Full Text] [Related]

  • 7. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA, de Prada P, Deng SX, Mittal A, Braskett M, Zhu X, Wilson IA, Landry DW.
    Biochemistry; 2004 Jun 29; 43(25):8067-76. PubMed ID: 15209502
    [Abstract] [Full Text] [Related]

  • 8. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D, Rahman A.
    Arthritis Res Ther; 2005 Jun 29; 7(1):R47-56. PubMed ID: 15642142
    [Abstract] [Full Text] [Related]

  • 9. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
    Liu Z, Song D, Kramer A, Martin AC, Dandekar T, Schneider-Mergener J, Bautz EK, Dübel S.
    J Mol Recognit; 1999 Jun 29; 12(2):103-11. PubMed ID: 10398401
    [Abstract] [Full Text] [Related]

  • 10. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs.
    Potter KN, Li Y, Capra JD.
    J Immunol; 1996 Oct 01; 157(7):2982-8. PubMed ID: 8816406
    [Abstract] [Full Text] [Related]

  • 11. A possible hydrolysis mechanism of beta-naphthyl acetate catalyzed by antibodies.
    Yuan YR, Xia ZX, Yang CH, Yang BH, Yeh M.
    Cell Res; 1998 Sep 01; 8(3):219-30. PubMed ID: 9791735
    [Abstract] [Full Text] [Related]

  • 12. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C, Randal M, Presta L, Carter P, Kossiakoff AA.
    J Mol Biol; 1993 Feb 20; 229(4):969-95. PubMed ID: 8095303
    [Abstract] [Full Text] [Related]

  • 13. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis.
    Xu J, Song J, Yan F, Chu H, Luo J, Zhao Y, Cheng X, Luo G, Zheng Q, Wei J.
    J Mol Recognit; 2009 Feb 20; 22(4):293-300. PubMed ID: 19277948
    [Abstract] [Full Text] [Related]

  • 14. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS, Air GM.
    Biochemistry; 1998 Jul 28; 37(30):10660-70. PubMed ID: 9692956
    [Abstract] [Full Text] [Related]

  • 15. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW, Shan L, Anchin JM, Linthicum DS, Edmundson AB.
    J Mol Biol; 1994 Feb 11; 236(1):247-74. PubMed ID: 7893280
    [Abstract] [Full Text] [Related]

  • 16. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
    Sompuram SR, Den W, Sharon J.
    J Immunol; 1996 Feb 01; 156(3):1071-81. PubMed ID: 8557981
    [Abstract] [Full Text] [Related]

  • 17. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
    Solem ST, Brandsdal BO, Smalås A, Jørgensen TØ.
    Mol Immunol; 2004 Apr 01; 40(18):1347-60. PubMed ID: 15072853
    [Abstract] [Full Text] [Related]

  • 18. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L.
    J Mol Biol; 1996 Jun 28; 259(5):957-69. PubMed ID: 8683598
    [Abstract] [Full Text] [Related]

  • 19. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH, Sandmaier BM, Stayton PS.
    Biophys J; 1998 Sep 28; 75(3):1473-82. PubMed ID: 9726949
    [Abstract] [Full Text] [Related]

  • 20. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J, Van Regenmortel MH, Vernet T, Altschuh D.
    J Mol Biol; 1996 Nov 22; 264(1):1-6. PubMed ID: 8950262
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.